Please Wait
Applying Filters...
menu
    • menu
    Polfa Tarchomin is a leading Polish pharmaceutical company with 200 year tradition in manufacture and sale of pharmaceutical products.

    Virtual Booth

    Contact Supplier

    Transo-Pharm GmbH works globally to supply Active Pharmaceutical Ingredients adhering to the highest quality & GMP standards.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2025-03-24

    Virtual Booth

    Contact Supplier

    LGM Pharma accelerates & optimizes the new product pathway from early development through commercialization.

    Virtual Booth

    Contact Supplier

    Gentec Pharmaceutical Group is focused on manufacturing & developing APIs/HPAPIs, Advanced Intermediates & Fine Chemicals.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2025-03-17

    Virtual Booth

    Contact Supplier

    Menu

    Incyte Corporation

    EVENTS

    • Webinars & Exhibitions

    DIGITAL CONTENT

    DEVELOPMENTS

    FINISHED DOSAGE FORMULATIONS

    INSPECTIONS & REGISTRATIONS

    PharmaCompass
    Xls

    Filters

    clear-filterReset all filters
    Filters Filter
    Cross PopUp
    FILTER :

    filter clear-filterReset all filters

    01 3PEMIGATINIB

    02 1RUXOLITINIB (RUXOLITINIB PHOSPHATE)

    03 1TAFASITAMAB

    filter clear-filterReset all filters

    filter clear-filterReset all filters

    filter clear-filterReset all filters

    PharmaCompass
    ListList of Suppliers
    refresh Reset Filter
    refresh Reset Filter
    product-page Supplier Virtual Booth
    price-trend Ask Us

    01

    Brand Name : OPZELURA

    U.S.A
    ELCC
    Not Confirmed
    arrow

    Brand Name : OPZELURA

    U.S.A
    arrow
    ELCC
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    Post an Enquiry Post an Enquiry
    Flag U.S.A
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Regulatory Info : Prescription

    Registration Country : Canada

    RUXOLITINIB (RUXOLITINIB PHOSPHATE)

    Incyte Corporation

    Dosage Form : CREAM

    Dosage Strength : 1.5%/W/W

    Packaging :

    Brand Name : OPZELURA

    Approval Date :

    Application Number : 2552434

    Regulatory Info : Prescription

    Registration Country : Canada

    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Market
    Place

    02

    Brand Name : PEMAZYRE

    U.S.A
    ELCC
    Not Confirmed
    arrow

    Brand Name : PEMAZYRE

    U.S.A
    arrow
    ELCC
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    Post an Enquiry Post an Enquiry
    Flag U.S.A
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Regulatory Info : Prescription

    Registration Country : Canada

    PEMIGATINIB

    Incyte Corporation

    Dosage Form : TABLET

    Dosage Strength : 4.5MG

    Packaging :

    Brand Name : PEMAZYRE

    Approval Date :

    Application Number : 2519933

    Regulatory Info : Prescription

    Registration Country : Canada

    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Market
    Place

    03

    Brand Name : PEMAZYRE

    U.S.A
    ELCC
    Not Confirmed
    arrow

    Brand Name : PEMAZYRE

    U.S.A
    arrow
    ELCC
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    Post an Enquiry Post an Enquiry
    Flag U.S.A
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Regulatory Info : Prescription

    Registration Country : Canada

    PEMIGATINIB

    Incyte Corporation

    Dosage Form : TABLET

    Dosage Strength : 9MG

    Packaging :

    Brand Name : PEMAZYRE

    Approval Date :

    Application Number : 2519941

    Regulatory Info : Prescription

    Registration Country : Canada

    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Market
    Place

    04

    Brand Name : PEMAZYRE

    U.S.A
    ELCC
    Not Confirmed
    arrow

    Brand Name : PEMAZYRE

    U.S.A
    arrow
    ELCC
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    Post an Enquiry Post an Enquiry
    Flag U.S.A
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Regulatory Info : Prescription

    Registration Country : Canada

    PEMIGATINIB

    Incyte Corporation

    Dosage Form : TABLET

    Dosage Strength : 13.5MG

    Packaging :

    Brand Name : PEMAZYRE

    Approval Date :

    Application Number : 2519968

    Regulatory Info : Prescription

    Registration Country : Canada

    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Market
    Place

    05

    Brand Name : MINJUVI

    U.S.A
    ELCC
    Not Confirmed
    arrow

    Brand Name : MINJUVI

    U.S.A
    arrow
    ELCC
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    Post an Enquiry Post an Enquiry
    Flag U.S.A
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Regulatory Info : Prescription

    Registration Country : Canada

    TAFASITAMAB

    Incyte Corporation

    Dosage Form : POWDER FOR SOLUTION

    Dosage Strength : 200MG/VIAL

    Packaging :

    Brand Name : MINJUVI

    Approval Date :

    Application Number : 2518627

    Regulatory Info : Prescription

    Registration Country : Canada

    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Market
    Place